Image of hands shaking on a blue background to show SMC recommends Roche’s Ocrevus for people with PPMS

Pfizer’s VYNDAQEL® (tafamidis) receives positive CHMP opinion

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of...
Cartoon image of westminster with big ben, london eye, red telephone box and houses of parliament to show ABPI responds to General Election result

ABPI responds to General Election result

The ABPI has responded to the General Election result welcoming the news and saying that it is looking forward to working with the new...
Woman sat on hospital examination bed with doctor, equipment and scans to show Breast cancer blood test could help target treatment

Breast cancer blood test could help target treatment

A breast cancer blood test can help identify rare mutations in advanced breast cancer and may enable patients to access effective treatments more quickly...
Janssen presents initial results for BCMA CAR-T therapy

Janssen presents initial results for BCMA CAR-T therapy

Janssen presents initial results for BCMA CAR-T therapy JNJ-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma. The...
hands shaking in front of a contract being signed by a man and a woman to show Servier and UCL collaborate on immune-inflammatory disease treatments

Servier and UCL collaborate on immune-inflammatory disease treatments

Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...
Man and woman shaking hands to show Acquisition of Ashfield Pharmacovigilance from UDG Healthcare

Forendo and Novartis partner on novel chronic liver disease treatments

Forendo and Novartis are to partner on novel chronic liver disease treatments. Forendo Pharma, a clinical stage drug development company focusing on novel treatments...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Graphic of Scotland with the Scottish flag over the top to show AstraZeneca and MSD's Lynparza™ now available in Scotland

AstraZeneca and MSD’s Lynparza™ now available in Scotland

AstraZeneca and MSD's Lynparza™ is now available in Scotland as the companies announce that olaparib monotherapy is now accepted for use by the Scottish...
Science technology equipment showing Novartis highlights progress in R&D pipeline

Novartis highlights progress in R&D pipeline

Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
Image of hands shaking on a blue background to show SMC recommends Roche’s Ocrevus for people with PPMS

MSD’s new HIV-1 treatment approved for use on the NHS

MSD's new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine▼...

Latest articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
hands holding smart phones to show Digital interventions for behaviour change

Digital interventions for behaviour change

New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
image of red and blue heart on purple background to show Acute aortic dissection is a 'ticking time bomb'

Acute aortic dissection is a ‘ticking time bomb’

Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...

Popular articles

Image of man and woman sat in waiting room holding their stomachs to show NICE rejects Janssen's Stelara for moderate to severe ulcerative colitis

NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis

The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Child sat on a bench playing with blocks to show Meningitis B infant vaccination programme shows 75% drop in cases over three years

Meningitis B infant vaccination programme shows 75% drop in cases over three years

Meningitis B infant vaccination programme shows 75% drop in cases over three years, these are the results of one of two independent meningitis B...
Image of a chart and table with a person standing in front of it and a person on top of it to show Integrated commercial deployment in life sciences and other 2020 health trends

Integrated commercial deployment in life sciences and other 2020 health trends

Syneos Health explore integrated commercial deployment in life sciences and discuss their new report covering 2020 health trends. Life science leaders aren’t launching with...
image of lungs, the left lung is bordered by orange, the right by blue to show AstraZeneca's Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription